Premium
Substantial variation in post‐engraftment infection prophylaxis and revaccination practice in autologous stem cell transplant patients
Author(s) -
Lim H. Y.,
Grigg A.
Publication year - 2016
Publication title -
internal medicine journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.596
H-Index - 70
eISSN - 1445-5994
pISSN - 1444-0903
DOI - 10.1111/imj.12992
Subject(s) - medicine , pneumocystis jirovecii , secondary prophylaxis , stem cell , pre exposure prophylaxis , immunology , intensive care medicine , human immunodeficiency virus (hiv) , men who have sex with men , biology , genetics , syphilis
There is a paucity of evidence supporting the necessity or duration of Pneumocystis jirovecii and antiviral prophylaxis as well as revaccination following autologous stem cell transplant ( ASCT ). A survey aimed at evaluating these policies was distributed to 34 ASCT centres across Australasia. The 26 survey respondents demonstrated significant heterogeneity in their infection prophylaxis and revaccination strategy post‐transplant despite the availability of consensual guidelines.